ResearcherMarker Therapeutics, Inc.Active in the last 2 years

Juan Fernando Vera

Verified by NIH RePORTER profile ID (good confidence)As of 9 November 2026

Matched on NIH RePORTER profile ID 9545556.

Their work

Papers: 0
Trials: 0
Grants: 3
Labs led: 1
Collaborators: 1

Papers, trials and grants by year

2025: 2 grants · 2026: 1 grant

Grants 3

Safety and Efficacy of a Multi-Tumor-Associated Antigen-Specific T Cell Therapy in Pancreatic Cancer Patients R01FD008756 ↗
Controlling Tumor Immune Escape in Pancreatic Cancer using a Dual T Cell Product Strategy R44CA287653 ↗
A Phase 1 Study of Patient-Derived Multi-Tumor Associated Antigen Specific T Cells (MT-601) Administered to Patients with Metastatic Pancreatic Cancer followin… R44CA295168 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Brandon Smaglo · 1 shared grant, 2025
- Grant A Phase 1 Study of Patient-Derived Multi-Tumor Associated Antigen Specific T Cells (MT-601) Administered to Patients wi… R44CA295168 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.